Eli Lilly and Company (LLY)
STRONG BUYAI-powered analysis, Wall Street analyst consensus, and market data for Eli Lilly and Company. Updated automatically — see why LLY is rated Buy today.
Updated 2h ago
Price
$1,413.79
Day change
-1.25%
Analysts Buy
86%
P/E ratio
65.3
Market cap
$1.35T
LLY price chart
AI analysis for LLY
Eli Lilly's recent uptick, buoyed by promising clinical updates on drugs like Zepbound, shows potential for continued growth in the obesity treatment space, but the hefty P/E ratio of 65.8x indicates the market may be pricing in a lot of optimism already.
Wall Street analyst ratings
Ask Stoki about LLY
Free with an account. It only takes an email.
Related stocks
More from Consumer & healthcare
Track LLY and 150+ more with StockIntel AI
Daily AI stock analysis, regularly updated ratings, and the Higher-or-Lower game — completely free.
Ratings are derived from Wall Street analyst consensus (via our market data partner) and AI-generated analysis. For informational purposes only — not financial advice. See our full disclaimer.